CA2007137A1 - Agent pour desensibiliser les humains et (ou) les animaux contre un allergene - Google Patents

Agent pour desensibiliser les humains et (ou) les animaux contre un allergene

Info

Publication number: CA2007137A1
Authority: CA; Canada
Prior art keywords: allergens; agent; allergen; venom; liposomes
Prior art date: 1989-03-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA 2007137

Other languages

English (en)

Inventor

Amy L. Collins

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-03-09

Filing date

1990-01-04

Publication date

1990-09-09

1989-03-09 Priority claimed from US07/320,795 external-priority patent/US5013555A/en

1990-01-04 Application filed by Individual filed Critical Individual

1990-09-09 Publication of CA2007137A1 publication Critical patent/CA2007137A1/fr

Status Abandoned legal-status Critical Current

Links

239000013566 allergen Substances 0.000 title claims abstract description 94
239000003795 chemical substances by application Substances 0.000 title claims abstract description 35
241001465754 Metazoa Species 0.000 title claims abstract description 23
239000002502 liposome Substances 0.000 claims abstract description 66
238000000034 method Methods 0.000 claims abstract description 34
238000000586 desensitisation Methods 0.000 claims abstract description 18
229960004784 allergens Drugs 0.000 claims description 39
GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical compound O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 claims description 19
231100000611 venom Toxicity 0.000 claims description 18
239000002435 venom Substances 0.000 claims description 16
210000001048 venom Anatomy 0.000 claims description 16
241000196324 Embryophyta Species 0.000 claims description 13
239000003814 drug Substances 0.000 claims description 8
229940079593 drug Drugs 0.000 claims description 7
239000013569 fungal allergen Substances 0.000 claims description 7
239000000284 extract Substances 0.000 claims description 6
239000013568 food allergen Substances 0.000 claims description 5
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 4
239000002578 wasp venom Substances 0.000 claims description 4
241000894006 Bacteria Species 0.000 claims description 3
108091003079 Bovine Serum Albumin Proteins 0.000 claims description 3
241000392928 Parachromis friedrichsthalii Species 0.000 claims description 3
239000013570 bacterial allergen Substances 0.000 claims description 3
239000003659 bee venom Substances 0.000 claims description 3
102000009843 Thyroglobulin Human genes 0.000 claims description 2
239000002671 adjuvant Substances 0.000 claims description 2
ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 claims description 2
229940098773 bovine serum albumin Drugs 0.000 claims description 2
229940046528 grass pollen Drugs 0.000 claims description 2
TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 claims description 2
229960000814 tetanus toxoid Drugs 0.000 claims description 2
229960002175 thyroglobulin Drugs 0.000 claims description 2
229940046536 tree pollen allergenic extract Drugs 0.000 claims description 2
PZEUTLIKVUEDLB-UHFFFAOYSA-N 2-[[[2-[[6-amino-2-[[2-[[6-amino-2-[[2-[[2-[[2-[[2-[[2-[2-[[1-[2-[[2-[[2-[[2-[[2-[[2-[[6-amino-2-[[2-[[2-[2-[[2-[[2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]acetyl]amino]propanoylamino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-methylbutanoyl]amino]acetyl]amino]-4-methylpentanoyl]pyrrolidine-2-carbonyl]amino]propanoylamino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-methylpentanoyl]amino]hexanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]-3-(carbamoylamino)propanoyl]-(3-amino-3-oxopropyl)carbamoyl]amino]pentanediamide Chemical compound CCC(C)C(NC(=O)CN)C(=O)NCC(=O)NC(C)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)O)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(CO)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(C(C)CC)C(=O)NC(CCCCN)C(=O)NC(CCCNC(N)=N)C(=O)NC(CCCCN)C(=O)NC(CNC(N)=O)C(=O)N(CCC(N)=O)C(=O)NC(CCC(N)=O)C(N)=O PZEUTLIKVUEDLB-UHFFFAOYSA-N 0.000 claims 2
241000256868 Dolichovespula maculata Species 0.000 claims 2
229940066369 honey bee venom Drugs 0.000 claims 2
229940066358 yellow hornet venom Drugs 0.000 claims 2
101000800130 Bos taurus Thyroglobulin Proteins 0.000 claims 1
230000001939 inductive effect Effects 0.000 abstract 1
230000003053 immunization Effects 0.000 description 20
150000002632 lipids Chemical class 0.000 description 20
238000002347 injection Methods 0.000 description 13
239000007924 injection Substances 0.000 description 13
208000026935 allergic disease Diseases 0.000 description 11
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
239000002158 endotoxin Substances 0.000 description 10
229920006008 lipopolysaccharide Polymers 0.000 description 10
206010020751 Hypersensitivity Diseases 0.000 description 8
230000000172 allergic effect Effects 0.000 description 7
208000010668 atopic eczema Diseases 0.000 description 7
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
230000007815 allergy Effects 0.000 description 6
150000003904 phospholipids Chemical class 0.000 description 6
229960005486 vaccine Drugs 0.000 description 6
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 5
239000000203 mixture Substances 0.000 description 5
210000002966 serum Anatomy 0.000 description 5
239000000243 solution Substances 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 4
229910019142 PO4 Inorganic materials 0.000 description 4
239000000969 carrier Substances 0.000 description 4
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
RNPXCFINMKSQPQ-UHFFFAOYSA-N dicetyl hydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(=O)OCCCCCCCCCCCCCCCC RNPXCFINMKSQPQ-UHFFFAOYSA-N 0.000 description 4
239000012071 phase Substances 0.000 description 4
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
239000010452 phosphate Substances 0.000 description 4
239000002953 phosphate buffered saline Substances 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
239000009342 ragweed pollen Substances 0.000 description 4
OZFAFGSSMRRTDW-UHFFFAOYSA-N (2,4-dichlorophenyl) benzenesulfonate Chemical compound ClC1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 OZFAFGSSMRRTDW-UHFFFAOYSA-N 0.000 description 3
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
241000256844 Apis mellifera Species 0.000 description 3
GZDFHIJNHHMENY-UHFFFAOYSA-N Dimethyl dicarbonate Chemical compound COC(=O)OC(=O)OC GZDFHIJNHHMENY-UHFFFAOYSA-N 0.000 description 3
238000002965 ELISA Methods 0.000 description 3
210000004556 brain Anatomy 0.000 description 3
239000000872 buffer Substances 0.000 description 3
238000005119 centrifugation Methods 0.000 description 3
230000001900 immune effect Effects 0.000 description 3
239000011780 sodium chloride Substances 0.000 description 3
239000002904 solvent Substances 0.000 description 3
208000024891 symptom Diseases 0.000 description 3
CITHEXJVPOWHKC-UUWRZZSWSA-N 1,2-di-O-myristoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCC CITHEXJVPOWHKC-UUWRZZSWSA-N 0.000 description 2
101001094887 Ambrosia artemisiifolia Pectate lyase 1 Proteins 0.000 description 2
101001123576 Ambrosia artemisiifolia Pectate lyase 2 Proteins 0.000 description 2
101001123572 Ambrosia artemisiifolia Pectate lyase 3 Proteins 0.000 description 2
101000573177 Ambrosia artemisiifolia Pectate lyase 5 Proteins 0.000 description 2
YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
241000588724 Escherichia coli Species 0.000 description 2
229930186217 Glycolipid Natural products 0.000 description 2
108060003951 Immunoglobulin Proteins 0.000 description 2
CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
208000002193 Pain Diseases 0.000 description 2
229920001213 Polysorbate 20 Polymers 0.000 description 2
241000607142 Salmonella Species 0.000 description 2
229920002684 Sepharose Polymers 0.000 description 2
241000256856 Vespidae Species 0.000 description 2
229940037003 alum Drugs 0.000 description 2
239000008346 aqueous phase Substances 0.000 description 2
230000001580 bacterial effect Effects 0.000 description 2
235000015278 beef Nutrition 0.000 description 2
230000000903 blocking effect Effects 0.000 description 2
125000004432 carbon atom Chemical group C* 0.000 description 2
229940106189 ceramide Drugs 0.000 description 2
ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
235000012000 cholesterol Nutrition 0.000 description 2
229940093541 dicetylphosphate Drugs 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
BPHQZTVXXXJVHI-UHFFFAOYSA-N dimyristoyl phosphatidylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCCCCCCCC BPHQZTVXXXJVHI-UHFFFAOYSA-N 0.000 description 2
-1 e.g. Substances 0.000 description 2
210000003743 erythrocyte Anatomy 0.000 description 2
238000001704 evaporation Methods 0.000 description 2
238000000605 extraction Methods 0.000 description 2
150000002270 gangliosides Chemical class 0.000 description 2
239000011521 glass Substances 0.000 description 2
230000028993 immune response Effects 0.000 description 2
238000002649 immunization Methods 0.000 description 2
102000018358 immunoglobulin Human genes 0.000 description 2
239000002919 insect venom Substances 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
210000000265 leukocyte Anatomy 0.000 description 2
238000012423 maintenance Methods 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
239000000463 material Substances 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
230000000737 periodic effect Effects 0.000 description 2
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
230000008569 process Effects 0.000 description 2
238000011160 research Methods 0.000 description 2
230000004044 response Effects 0.000 description 2
238000001179 sorption measurement Methods 0.000 description 2
239000000126 substance Substances 0.000 description 2
238000012360 testing method Methods 0.000 description 2
230000003442 weekly effect Effects 0.000 description 2
FROLUYNBHPUZQU-IIZJPUEISA-N (2R,3R,4S,5R)-2-(hydroxymethyl)-6-[3-[3-[(3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropoxy]propoxy]oxane-3,4,5-triol Chemical compound OC[C@H]1OC(OCCCOCCCOC2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O FROLUYNBHPUZQU-IIZJPUEISA-N 0.000 description 1
PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
244000036975 Ambrosia artemisiifolia Species 0.000 description 1
235000003129 Ambrosia artemisiifolia var elatior Nutrition 0.000 description 1
APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
206010002198 Anaphylactic reaction Diseases 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
101710114192 Elicitin Proteins 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
241000283086 Equidae Species 0.000 description 1
208000010201 Exanthema Diseases 0.000 description 1
206010052140 Eye pruritus Diseases 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
240000009088 Fragaria x ananassa Species 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
241000446313 Lamella Species 0.000 description 1
206010024769 Local reaction Diseases 0.000 description 1
206010028735 Nasal congestion Diseases 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
SUHOOTKUPISOBE-UHFFFAOYSA-N O-phosphoethanolamine Chemical compound NCCOP(O)(O)=O SUHOOTKUPISOBE-UHFFFAOYSA-N 0.000 description 1
BZQFBWGGLXLEPQ-UHFFFAOYSA-N O-phosphoryl-L-serine Natural products OC(=O)C(N)COP(O)(O)=O BZQFBWGGLXLEPQ-UHFFFAOYSA-N 0.000 description 1
REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
241000256835 Polistes Species 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
241000607768 Shigella Species 0.000 description 1
206010043521 Throat irritation Diseases 0.000 description 1
108010034949 Thyroglobulin Proteins 0.000 description 1
241000656145 Thyrsites atun Species 0.000 description 1
208000024780 Urticaria Diseases 0.000 description 1
241000700605 Viruses Species 0.000 description 1
JLPULHDHAOZNQI-JLOPVYAASA-N [(2r)-3-hexadecanoyloxy-2-[(9e,12e)-octadeca-9,12-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC JLPULHDHAOZNQI-JLOPVYAASA-N 0.000 description 1
LEBBDRXHHNYZIA-LDUWYPJVSA-N [(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] n-[(z)-1,3-dihydroxyoctadec-4-en-2-yl]carbamate Chemical compound CCCCCCCCCCCCC\C=C/C(O)C(CO)NC(=O)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O LEBBDRXHHNYZIA-LDUWYPJVSA-N 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
238000010306 acid treatment Methods 0.000 description 1
125000002252 acyl group Chemical group 0.000 description 1
208000030961 allergic reaction Diseases 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
229960003942 amphotericin b Drugs 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
230000036783 anaphylactic response Effects 0.000 description 1
208000003455 anaphylaxis Diseases 0.000 description 1
235000003484 annual ragweed Nutrition 0.000 description 1
230000003466 anti-cipated effect Effects 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
239000003080 antimitotic agent Substances 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
238000003556 assay Methods 0.000 description 1
208000010216 atopic IgE responsiveness Diseases 0.000 description 1
239000011324 bead Substances 0.000 description 1
229960000074 biopharmaceutical Drugs 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
238000009835 boiling Methods 0.000 description 1
235000006263 bur ragweed Nutrition 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
239000005018 casein Substances 0.000 description 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
235000021240 caseins Nutrition 0.000 description 1
210000004027 cell Anatomy 0.000 description 1
235000003488 common ragweed Nutrition 0.000 description 1
239000000470 constituent Substances 0.000 description 1
230000007423 decrease Effects 0.000 description 1
239000003975 dentin desensitizing agent Substances 0.000 description 1
229950006137 dexfosfoserine Drugs 0.000 description 1
150000001982 diacylglycerols Chemical class 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
229960003724 dimyristoylphosphatidylcholine Drugs 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
ZGSPNIOCEDOHGS-UHFFFAOYSA-L disodium [3-[2,3-di(octadeca-9,12-dienoyloxy)propoxy-oxidophosphoryl]oxy-2-hydroxypropyl] 2,3-di(octadeca-9,12-dienoyloxy)propyl phosphate Chemical compound [Na+].[Na+].CCCCCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COP([O-])(=O)OCC(O)COP([O-])(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC ZGSPNIOCEDOHGS-UHFFFAOYSA-L 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
238000005538 encapsulation Methods 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
201000005884 exanthem Diseases 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
239000012894 fetal calf serum Substances 0.000 description 1
235000021022 fresh fruits Nutrition 0.000 description 1
150000002298 globosides Chemical class 0.000 description 1
229940098197 human immunoglobulin g Drugs 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
230000009610 hypersensitivity Effects 0.000 description 1
230000005847 immunogenicity Effects 0.000 description 1
239000003547 immunosorbent Substances 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
230000003993 interaction Effects 0.000 description 1
238000011005 laboratory method Methods 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
244000045947 parasite Species 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
102000013415 peroxidase activity proteins Human genes 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
229960003531 phenolsulfonphthalein Drugs 0.000 description 1
150000003905 phosphatidylinositols Chemical class 0.000 description 1
YHHSONZFOIEMCP-UHFFFAOYSA-O phosphocholine Chemical compound C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 description 1
BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
235000018102 proteins Nutrition 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
239000002510 pyrogen Substances 0.000 description 1
230000001698 pyrogenic effect Effects 0.000 description 1
235000009736 ragweed Nutrition 0.000 description 1
206010037844 rash Diseases 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
235000014102 seafood Nutrition 0.000 description 1
238000000926 separation method Methods 0.000 description 1
206010041232 sneezing Diseases 0.000 description 1
230000007928 solubilization Effects 0.000 description 1
238000005063 solubilization Methods 0.000 description 1
238000000527 sonication Methods 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
239000011550 stock solution Substances 0.000 description 1
235000021012 strawberries Nutrition 0.000 description 1
239000000758 substrate Substances 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
230000008961 swelling Effects 0.000 description 1
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
229940033663 thimerosal Drugs 0.000 description 1
YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
235000013311 vegetables Nutrition 0.000 description 1
238000003260 vortexing Methods 0.000 description 1
229940045949 wasp venoms Drugs 0.000 description 1

Landscapes

Medicinal Preparation (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

CA 2007137 1989-03-09 1990-01-04 Agent pour desensibiliser les humains et (ou) les animaux contre un allergene Abandoned CA2007137A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US320,795		1989-03-09
US07/320,795 US5013555A (en)	1988-05-05	1989-03-09	Agent for desensitizing man and/or animals against an allergen

Publications (1)

Publication Number	Publication Date
CA2007137A1 true CA2007137A1 (fr)	1990-09-09

Family

ID=23247902

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 2007137 Abandoned CA2007137A1 (fr)	1989-03-09	1990-01-04	Agent pour desensibiliser les humains et (ou) les animaux contre un allergene

Country Status (1)

Country	Link
CA (1)	CA2007137A1 (fr)

1990
- 1990-01-04 CA CA 2007137 patent/CA2007137A1/fr not_active Abandoned

Legal Events

Date	Code	Title	Description
1992-07-04	FZDE	Dead

Publication	Publication Date	Title
US5049390A (en)	1991-09-17	Liposome containing immunotherapy agents for treating IgE mediated allergies
US5013555A (en)	1991-05-07	Agent for desensitizing man and/or animals against an allergen
AU631377B2 (en)	1992-11-26	Affinity associated vaccine
US5026557A (en)	1991-06-25	Adjuvant composition
US6004534A (en)	1999-12-21	Targeted polymerized liposomes for improved drug delivery
US5340588A (en)	1994-08-23	Liposphere carriers of vaccines
US4053585A (en)	1977-10-11	Immunological preparations
Wassef et al.	1994	Liposomes as carriers for vaccines
US6093406A (en)	2000-07-25	Vaccine for induction of immunity to malaria
US6117449A (en)	2000-09-12	Method for inducing a systemic immune response to a hepatitis antigen
JP2009242412A (ja)	2009-10-22	Ｔ細胞介在の病気を治療するための製剤と方法
EP0356340B1 (fr)	1994-11-02	Vaccin à affinité associée
US5897873A (en)	1999-04-27	Affinity associated vaccine
US5888519A (en)	1999-03-30	Encapsulated high-concentration lipid a compositions as immunogenic agents to produce human antibodies to prevent or treat gram-negative bacterial infections
US6749831B1 (en)	2004-06-15	Vaccine against lipopolysaccharide core
Green et al.	1995	Liposomal vaccines
JPH01500119A (ja)	1989-01-19	Ｇｍ２に対する抗体の産生を賦活又は増強させるためのワクチン
CA2007137A1 (fr)	1990-09-09	Agent pour desensibiliser les humains et (ou) les animaux contre un allergene
JP2001506256A (ja)	2001-05-15	免疫系のＴｈ２活性のダウン−レギュレーションのためのマイコバクテリア・ワクチン
Arora et al.	1991	Liposomes as vehicle for allergen presentation in the immunotherapy of allergic diseases
NO851389L (no)	1985-10-07	Fremgangsmaate for fremstilling av liposomer.
Richards et al.	1996	Liposomal subunit vaccines: effects of lipid A and aluminum hydroxide on immunogenicity
Lukes	1992	Ascaris suum—vaccination of mice with liposome encapsulated antigen
AU667028B2 (en)	1996-03-07	Lipid A composition as immunogenic agents to prevent or treat gram-negative bacterial infections
WO1990001947A1 (fr)	1990-03-08	Vaccin a affinite associee